Navigation Links
In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
Date:6/17/2008

SAN DIEGO, June 17 /PRNewswire/ -- Leading a trend of unprecedented growth in biotechnology innovation, targeted therapies with companion molecular diagnostics have built significant traction in the past year in terms of development and usage, according to a new Deloitte study released today at the 2008 BIO International Convention in San Diego.

Findings from the Deloitte report support the need to measure innovation in the market, in addition to the lab. Out of six biotechnology innovations measured, the study found that four (targeted therapies, monoclonal antibodies, radiotherapy and drug device combinations) advanced significantly in 2007, marking a year of unprecedented progress and commercial impact. Targeted therapies with companion molecular diagnostics have experienced the most profound surge in realization, rising 50 percent in just three years.

Developed to track the pace and progress of therapeutic-based technologies, the Deloitte report includes both quantitative research leveraging a proprietary index model and qualitative insights and analyses based on interviews with leading life sciences industry executives.

"Given the volatility and the pace of scientific discovery in recent years, there is a need for a fact-based analysis to better understand which innovations are emerging as the most promising and, conversely, which technologies are losing ground," said Matthew Hudes, U.S. managing principal, Biotechnology, for Deloitte Consulting LLP's Life Sciences & Health Care practice, and the director of the study. "As a first step toward more personalized treatments, targeted therapies with companion diagnostics are reaching more patients. However, there remain significant economic, reimbursement and regulatory challenges that could prevent valuable treatments from becoming available to people who need them."

Using data collected over the past six years, Deloitte researchers created a three-stage measurement model coverin
'/>"/>

SOURCE Deloitte
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
5. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
7. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
8. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
9. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
10. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
11. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...nthrax Vaccine Program must be stopped. Scott Mil...ot;A Call to Arms:2009 Edition" and the one-h...he Human Anthrax Vaccine Story" to inform the...secret government science turned into for-profit h...s victims. It is available for world-wide licensi...
(Date:11/4/2009)...ewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq:...the third quarter ended September 30, 2009. ,,... improved to $31.0 million or $0.33 per share, as ...er share in the third quarter of 2008. ,, Ne...ng efficiencies as compared to a year ago. Total ...
(Date:11/4/2009)...wire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ...ucts for regenerative healing, announced today tha...ment with Community Tissue Services (CTS), with an...nt replaces an existing contract between the two c...der the terms of the agreement, CTS will supply Os...
(Date:11/4/2009)...n situ FTIR analysis has become a standard tool in...oviding information rich data that allows a more t...lopment and scale-up of chemical processes. METTL...e Development of Batch and Continuous Chemical Pro... Process Analytical Technology (PAT) Tool on Novem...
Breaking Biology Technology:Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10Osteotech Secures 10-Year Tissue Supply Agreement 2Osteotech Secures 10-Year Tissue Supply Agreement 3Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool 2
...nnounced today that it will present at the Lehman ...nce on Wednesday, March 19, 2008 at 9:30 a.m.,East...ahady, Senior Vice,President, Wyeth and President,...l be webcast live for investors at, http://www.wye...ference., Wyeth is one of the world,s largest res...
... /PRNewswire-FirstCall/,-- Evotec AG (Frankfurt St..., President & CEO and Dr John Kemp, Chief Research...nd Company 28th Annual Health Care,Conference in B...me: 11.00 am EDT (04.00 pm CET/03.00 pm GMT...otel, Boston, US, A live webcast of the presentat...
...asdaq: BNVI ) announced today the appointment of .... Mr. Drapeau has extensive financial,management e...ience,companies., "We are quite excited to have a...., Bionovo,s Chairman and CEO. "Lou is particularl...ich face emerging life science,companies. He is a ...
Other Biology Technology:Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference 2Louis Drapeau Joins Bionovo's Board of Directors 2Louis Drapeau Joins Bionovo's Board of Directors 3
(Date:11/3/2009)... WEST LAFAYETTE, Ind. - Chief executives in 35 of ...ut 129 times their "ideal salaries" in 2008, accor...d by a Purdue University researcher to determine f...g economic and corporate governance issues of the ...," said Venkat Venkatasubramanian, a professor of ...
(Date:11/3/2009)...ATER, OKAfrican violets have a mixed reputation. T...aves make them a favorite among home gardeners and...ed as temperamental: a precise recipe of light, mo...ilizer is required to encourage african violets to...y scientists Julia C. Brotton and Janet C. Cole fr...
(Date:11/3/2009)...dian rhythm is like an orchestra the united expre...n chemical may serve as the conductor, or at least...de (H 2 O 2 ), the active ingredient in color safe...roxide may act as a signal for the active and rest...iologists suggests. , A study published in the j...
Breaking Biology News(10 mins):New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4For African violets, 'hands off' means healthier 2Not just bleach: Hydrogen peroxide may tell time for living cells 2Not just bleach: Hydrogen peroxide may tell time for living cells 3Sinapis Pharma Announces Frederick Frank as Consultant 56499 1Sinapis Pharma Announces Frederick Frank as Consultant 56499 2ForteBio Inc to Present at Thomas Weisel Partners Healthcare Conference 2009 56494 1Making connections the key to overcoming shame 56491 1Making connections the key to overcoming shame 56491 2
...ave broad implications for women,s fertility treat...e, female mice have a renewable egg supply in thei...lay from Prince Henry,s Institute and Associate Pr...omy and Cell Biology, has sparked controversy amon...ore than 50 years, that female mammals are born wi...
... patients may soon be possible, thanks to a discov...ia neuroscience researchers who have found a new s... chemicals are lost from brain cells during stroke...ims. , The findings were published recently in Sc...ext month,s issue of Nature Reviews Neuroscience. ...
...can be effectively repaired by tissue engineering ...process concludes research led by scientists at th...of tissue engineered cartilage implanted in injure...e July 2006 (Volume 12, Number 7) issue of Tissue ...e tissue can grow and mature when implanted into p...
Other Biology News:Fertility hope as study shows eggs survive in older ovaries 2UBC researchers find stroke death channel 2
Rabbit Anti-JTB Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human NPM Monoclonal Antibody, Unconjugated, Clone 5E3 from AbD Serotec
Pyrophosphate Colorimetric / Fluorometric (resorufin) Assay Kit, PiPer from Molecular Probes (Invitrogen)
Captivate magnetic separator for six microtubes from Molecular Probes (Invitrogen)
Biology Products: